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Available online 3 March 2007The neurotrophin BDNF regulates the activity-dependent modifications
of synaptic strength in the CNS. Physiological and biochemical
evidences implicate the NMDA glutamate receptor as one of the targets
for BDNFmodulation. In the present study, we investigated the effect of
BDNF on the expression and plasma membrane abundance of NMDA
receptor subunits in cultured hippocampal neurons. Acute stimulation
of hippocampal neurons with BDNF differentially upregulated the
protein levels of the NR1, NR2A and NR2B NMDA receptor subunits,
by a mechanism sensitive to transcription and translation inhibitors.
Accordingly, BDNF also increased the mRNA levels for NR1, NR2A
and NR2B subunits. The neurotrophin NT3 also upregulated the pro-
tein levels of NR2A and NR2B subunits, but was without effect on the
NR1 subunit. The amount of NR1, NR2A and NR2B proteins
associated with the plasma membrane of hippocampal neurons was
differentially increased by BDNF stimulation for 30 min or 24 h. The
rapid upregulation of plasma membrane-associated NMDA receptor
subunits was correlated with an increase in NMDA receptor activity.
The results indicate that BDNF increases the abundance of NMDA
receptors and their delivery to the plasma membrane, thereby
upregulating receptor activity in cultured hippocampal neurons.
© 2007 Elsevier Inc. All rights reserved.Introduction
The neurotrophin brain-derived neurotrophic factor (BDNF)
promotes neuronal survival and differentiation, and regulates sy-
naptic transmission and plasticity (reviewed in Bramham and Mes-
saoudi, 2005; Kalb, 2005; Lu et al., 2005). BDNF rapidly potentiates
excitatory synaptic transmission in cultured cerebrocortical and
hippocampal neurons, in part by enhancing presynaptic neuro-
transmitter release (Lessmann and Heumann, 1998; Takei et al.,
1998). Post-synaptically, BDNF enhances glutamatergic synaptic
transmission by regulating the phosphorylation ofNMDA (N-methyl-
D-aspartate) receptors (Suen et al., 1997; Lin et al., 1998; Alder et al.,⁎ Corresponding author. Fax: +351 239 480 208.
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doi:10.1016/j.mcn.2007.02.0192005), thereby enhancing NMDA receptor activity (Levine et al.,
1998; Song et al., 1998), increasing synaptic clustering of NMDA
receptors in cultured hippocampal neurons (Elmariah et al., 2004),
and upregulating AMPA receptor protein levels (Narisawa-Saito
et al., 1999a). Accordingly, BDNF has been implicated in activity-
dependent synaptic plasticity, including the early- and late phases of
long-term potentiation (LTP) induced by high-frequency stimulation
(reviewed in Bramham and Messaoudi, 2005). Activity-dependent
changes in synaptic strength are thought to underlie learning and
memory formation (Lynch, 2004).
NMDA receptors are glutamate, glycine and voltage-dependent
ion channels characterized by their high calcium permeability. In
the hippocampus, NMDA receptors are heteromeric complexes
composed of at least one NR1 subunit and one or more of the two
subunits, NR2A and NR2B (Sheng et al., 1994). Both NR1 and
NR2 subunits are required to form a functional ionotropic receptor
(Meguro et al., 1992; Monyer et al., 1994; Dingledine et al., 1999),
but different NR2 subunits confer distinct kinetic properties to the
NMDA receptors (Monyer et al., 1994). Some NMDA receptors
may also include an NR3 subunit (either NR3A or NR3B) as part of
the tetrameric structure (Chatterton et al., 2002). Before synapse
formation in developing hippocampal neurons, NMDA receptors
consist predominantly of NR1 and NR2B subunits (Tovar and
Westbrook, 1999). NR2B seems to remain in NMDA receptors that
are primarily extrasynaptic after synapse formation, although
NR2B-containing NMDA receptors are also found at the synapse.
This subunit composition is found in NMDA receptors present in
synaptic and extrasynaptic regions after synapse formation. In con-
trast, NR2A subunit progressively increases its expression (Monyer
et al., 1994; Sheng et al., 1994; Margottil and Domenici, 2003) and
is incorporated at synaptic sites (Stocca and Vicini, 1998; Tovar and
Westbrook, 1999). The mechanisms controlling the switch in the
composition of synaptic NMDA receptors from NR2B- to NR2A-
containing receptors are not well understood (Barria and Malinow,
2002), but studies in cortical neurons showed that the expression of
NMDA receptor subunits is regulated by neuronal activity (Muzet
and Dupont, 1996).
BDNF enhances the phosphorylation of NR1 and NR2B sub-
units in hippocampal and cortical neurons (Lin et al., 1998), and
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et al., 1998; Levine and Kolb, 2000). Phosphorylation of NR2B by
Fyn was suggested to contribute to the increase of glutamatergic
synaptic transmission by BDNF (Alder et al., 2005), and tyrosine
phosphorylation of the NR2B subunit was also associated with LTP
in the hippocampal CA1 region (Nakazawa et al., 2001). In addition
to these rapid effects of BDNF on NMDA receptors, recent studies
showed that BDNF increases the translation of the mRNA for NR1
in cultured cerebrocortical neurons (Schratt et al., 2004), suggesting
that the neurotrophin may also regulate the abundance of NMDA
receptors in the hippocampus. Although NMDA receptors were
initially thought to be relatively stable in the membrane, recent
studies have indicated that their surface expression is dynamic and
regulated (Nong et al., 2004). Thus, the BDNF-induced upregula-
tion of glutamatergic activity may also be due to the delivery of
NMDA receptors to the plasma membrane. In the present study we
investigated the short- and long-term effects of BDNF on the
cellular and plasma membrane abundance of NMDA receptor
subunits in cultured hippocampal neurons, and correlated the results
with the effects of BDNF on the activity of the receptors.
Results
Effect of BDNF on the total protein levels of NMDA receptor
subunits
To evaluate the acute effects of BDNF on the abundance of
NMDA receptor subunits, 7 DIV cultured hippocampal neurons
were incubated with or without 100 ng/ml BDNF, for various
periods of time (15 min–24 h). The NMDA receptor subunit NR1,
NR2A and NR2B protein levels were determined by Western Blot-
ting (Figs. 1A, C and E). BDNF upregulated NR1 subunits rapidly
and in a sustained manner. Significant effects were observed after
30 min to 12 h incubation with BDNF. The neurotrophin also did
upregulate NR2A and NR2B subunits, but with a distinct kinetics.
NR2A protein levels were significantly increased for longer periods
of incubation with BDNF (3 h to 12 h), while NR2B protein levels
were enhanced by brief BDNF stimulation periods (1 h to 3 h). After
24 h of stimulation with BDNF the NR1 and NR2A protein levels
were still slightly higher than the control, whereas a small reduction
of NR2B was observed. NR2C and NR2D subunits were
undetectable (data not shown), consistent with the lack of these
NMDA receptor subunits in the hippocampus (e.g. Janssens and
Lesage, 2001). BDNF also upregulated the amount of NR1, NR2A
and NR2B subunits in more mature hippocampal neurons, cultured
for 14 DIV (Fletcher et al., 1991; Figs. 1B, D and F). In these cells
BDNF induced a sustained increase in NR1 protein levels, parti-
cularly for incubation periods of 5 h, 6 h and 24 h. The NR2A
subunit was also upregulated by BDNF for long periods of incu-
bation with BDNF (6 h, 12 h and 24 h). In contrast, the NR2B
subunit was upregulated only by short incubations with BDNF, as
observed for 7 DIV (Fig. 1F). Activation of Trk neurotrophin
receptors was required for upregulation of NR1, NR2A and NR2B
receptor subunits by BDNF, since no effect was observed when
neurons were incubated with heat-inactivated BDNF (Figs. 2A–C).
Furthermore, pre-incubation of hippocampal neurons with the Trk
inhibitor K252a abrogated the effects of BDNF, although the
inhibitor also upregulated the NR1 protein levels in the absence of
neurotrophin (not shown).
In contrast with the results obtained with the hippocampal neu-
rons, incubation of cultured cerebellar granule cells with 100 ng/mlBDNF, for 2 h or 6 h, did not increase the protein levels of NR1,
NR2A and NR2B subunits (Figs. 2D–F). These results indicate that
the BDNF-induced upregulation of the NMDA receptor subunits is
specific for hippocampal neurons.
Incubation of hippocampal neurons with a different neurotro-
phin, neurotrophin-3 (NT3), which binds preferentially to the TrkC
receptors (Dechant, 2001), also increased the protein levels of
NR2A and NR2B subunits (Figs. 3B and C), but was without effect
on NR1 subunit (Fig. 3A), indicating that this neurotrophin also
modulates the levels of the NMDA receptor subunits.
Since BDNF is known to upregulate translation (e.g. Takei et al.,
2001) we studied whether de novo protein synthesis could account
for the BDNF-induced increase in NR1, NR2A and NR2B NMDA
receptor subunits. We used two translation inhibitors, emetine and
anisomycin, and the hippocampal neurons were stimulated with
BDNF for 3 h, in the presence or in the absence of the protein
synthesis inhibitors. Pre-incubation of cells with emetine (2 μM) or
anisomycin (2 μM) abolished the effect of BDNF on NR1, NR2A
and NR2B subunits (Fig. 4). None of the protein synthesis inhibitors
altered the NR1, NR2A and NR2B protein levels under control
conditions. These results are in agreement with the long half-life
determined for the NR2A/B subunits in cultured cerebellar granule
cells, and with the turn-over rate of NR1 in the same preparation
(Huh and Wenthold, 1999). Taken together, the results indicate that
BDNF affects NMDA receptor subunits by increasing protein
synthesis and suggest that a reduction in protein degradation is not
involved.
Effect of BDNF in the transcription activity of NMDA receptor
subunits
The effects of BDNF on protein synthesis may be due to an
increase in transcription activity (Messaoudi et al., 2002) and/or to
direct regulation of the protein synthesis machinery (Takei et al.,
2001). Therefore, the role of transcription in the BDNF-induced
upregulation of NR1, NR2A and NR2B protein levels was inves-
tigated using two transcription inhibitors, α-amanitine and actino-
mycin D. As for the translation inhibitors, pre-incubation of the
cultures with α-amanitine (1.5 μM) or actinomycin D (1.5 μM)
abolished the BDNF-induced upregulation of the NR1, NR2A and
NR2B protein levels, but was without effect on the abundance of the
NMDA receptor subunits in the absence of BDNF (Fig. 5). To
further confirm that the effects of BDNF occur at the transcription
level, real-time PCR using the SYBR green assay was performed
(Fig. 6). Stimulation with BDNF for 30 min or 3 h significantly
increased the mRNA levels of NR1 and NR2A, although the effect
was less significant in the latter incubation period. A delayed
increase in themRNA levels for NR2Bwas also observed after 3 h of
stimulation with BDNF (Fig. 6). These results point to a regulation
of NR1, NR2A andNR2BNMDA receptor subunits by BDNF at the
transcription level. Moreover, they clearly correlate the several fold
increase in NR1 and NR2A mRNA with the sustained raise in the
respective protein levels. On the other hand, the transient increase in
NR2B protein levels induced by BDNF is also correlated with a
relatively weaker effect on the mRNA levels of this specific subunit.
Effect of BDNF on NMDA receptor subunit protein levels at the
plasma membrane
In cerebellar granule neurons there is a large intracellular pool of
NR1 subunits, whereas most NR2A and NR2B subunit proteins are
Fig. 1. BDNF upregulates the protein levels of the NR1, NR2A and NR2B NMDA receptor subunits in cultured hippocampal neurons. Seven DIV (A, C, E) or 14
DIV (B, D, F) cultured hippocampal neurons were incubated with or without 100 ng/ml BDNF (15 min, 30 min, 1 h, 2 h, 3 h, 4 h, 5 h, 6 h, 12 h and 24 h), as
indicated. Total NR1, NR2A and NR2B protein levels were determined by Western Blot. Control (0 h) protein levels of NMDA receptor subunits were set to
100%. β-tubulin was used as loading control. The results are the average ±S.E.M. of 5–9 independent experiments, performed in independent preparations.
Statistical analysis was performed by one-way ANOVA, followed by the Dunnett's test. *P<0.05, **P<0.01.
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these cells the NR2 subunit availability determines the number of
cell surface receptors (Prybylowski et al., 2002). This may also
apply to hippocampal neurons, where the majority of NR2B is
associated with the plasma membrane, whereas a significant frac-
tion of NR1 is intracellular (Hall and Soderling, 1997). Therefore,
we investigated whether the upregulation of NMDA receptor sub-units by BDNF affects the NR1 and NR2 protein levels in the
plasma membrane of cultured hippocampal neurons. The cell
surface distribution of the NMDA receptor subunits NR1, NR2A
and NR2B was determined by biotinylation of cell surface proteins,
under control conditions and after treatment with 100 ng/ml BDNF.
Surface proteins were then collected with streptavidin-coupled
beads, and subjected to Western Blotting (Fig. 7). BDNF treatment
Fig. 2. Heat-inactivated BDNF does not upregulate NR1, NR2A or NR2B protein levels (A–C). Hippocampal neurons were incubated with or without 100 ng/ml
heat-inactivated BDNF (95 °C, 5 min), for 3 h. NR1, NR2A and NR2B protein levels were measured byWestern Blot. BDNF does not affect the protein levels of
NR1, NR2A and NR2B subunits in cultured cerebellar granule neurons (D–F). The cells were incubated with or without 100 ng/ml BDNF (2 h and 6 h), and the
NR1, NR2A and NR2B protein levels were measured by Western blot. Control (unstimulated) protein levels of NMDA receptor subunits were set to 100%. β-
tubulin was used as loading control. The results are the average ±S.E.M. of 4–9 independent experiments, performed in independent preparations. Statistical
analysis was performed by one-way ANOVA, followed by the Dunnett's test.
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associated with the plasma membrane, whereas longer incubations
with the neurotrophin (24 h) were required to significantly increase
surface NR2A. These data suggest that BDNF differentially regu-
lates the translocation of the NMDA receptors with different subunit
compositions to the plasma membrane in cultured hippocampal
neurons.Fig. 3. Incubation of hippocampal neurons with NT3 increased the protein levels of
neurons were incubated with or without 100 ng/ml NT3 for 2 h and 6 h, and total N
Blot. Control (unstimulated) protein levels of NMDA receptor subunits were set to
S.E.M. of 5–8 independent experiments, performed in independent preparations.
Dunnett's test. *P<0.05, **P<0.01.Effect of BDNF on the NMDA-induced [Ca2+]i changes
NMDA receptors are cation channels, permeable to Na+ and
Ca2+, and activation of these receptors increases the intracellular
free calcium concentration ([Ca2+]i) (e.g. Duarte et al., 1996). The
effect of BDNF on the activity of NMDA receptors was inves-
tigated in single cultured hippocampal neurons, by Fura-2 imaging.NR2A and NR2B, but was without effect on NR1 protein levels. Seven DIV
R1 (A), NR2A (B) and NR2B (C) protein levels were measured by Western
100%. β-tubulin was used as loading control. The results are the average±
Statistical analysis was performed by one-way ANOVA, followed by the
Fig. 4. Translation inhibitors impair the BDNF-induced upregulation of NR1, NR2A and NR2B protein levels. Seven DIV hippocampal neurons were incubated
with or without 100 ng/ml BDNF for 3 h, in the presence or in the absence of emetine (2.0 μM) (A, C, E) or anisomycin (2.0 μM) (B, D, F). When the inhibitors
were used the cells were pre-incubated with the compounds for 30 min before stimulation with BDNF. Total NR1, NR2A and NR2B protein levels were
measured by Western Blot. Control protein levels of NMDA receptor subunits were set to 100%. β-tubulin was used as loading control. The results are the
average±S.E.M. of 6–12 independent experiments, performed in independent preparations. Statistical analysis was performed by one-way ANOVA, followed by
the Dunnett's test. *P<0.05, **P<0.001.
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Mg2+-free medium, increased the Fura-2 fluorescence ratio (F340/
F380) (Fig. 8). When the cells were pre-incubated with BDNF for
40 min there was an increase in the NMDA-induced [Ca2+]i rise.
The [Ca2+]i response to activation of NMDA receptors is due to
Ca2+ entry through the receptor channels and to Ca2+ influx through
voltage-gated Ca2+ channels (Duarte et al., 1996). To determinewhether the effect of BDNF on the responses to NMDA is due to an
increase in the activity of voltage-gated Ca2+ channels, rather than
to a direct change in the activity of the receptors, we studied the
effect of the neurotrophin on the initial [Ca2+]i changes caused by
KCl depolarization. Perfusion of the cells with a solution where
NaCl was isoosmotically replaced by 30 mM KCl rapidly increased
the [Ca2+]i, but the magnitude of the response was not affected by
Fig. 5. Transcription inhibitors prevent the BDNF-induced upregulation of the NR1, NR2A and NR2B protein levels. Seven DIV cultured hippocampal
neurons were incubated with or without 100 ng/ml BDNF for 3 h, in the presence or in the absence of α-amanitine (1.5 μM) (A, C, E) or actinomycin D
(1.5 μM) (B, D, F). When the inhibitors were used the cells were pre-incubated with the compounds for 30 min before stimulation with BDNF. Total NR1, NR2A
and NR2B protein levels were measured by Western Blot. Control protein levels of NMDA receptor subunits were set to 100%. β-tubulin was used as loading
control. The results are the average±S.E.M. of 5–10 independent experiments, performed in independent preparations. Statistical analysis was performed by
one-way ANOVA, followed by the Dunnett's test. *P<0.05.
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strongly suggest that the BDNF-induced increase in the [Ca2+]i
responses to NMDA are due, at least in part, to an upregulation of
the plasma membrane-associated receptors.
Discussion
BDNF has been shown to play important roles in the regulation
of the glutamatergic synaptic transmission and in the early- and late-
phases of LTP (reviewed in Bramham andMessaoudi, 2005), but theunderlying mechanisms are still not fully understood. The rapid
effects of BDNF on the post-synaptic responses to glutamate have
been largely attributed to the phosphorylation of NMDA receptor
subunits, which increases receptor activity (Levine et al., 1998;
Levine and Kolb, 2000). In the present study, we showed that BDNF
also induces a rapid delivery of NR2B-containing NMDA receptors
to the plasma membrane, which correlated with an increased [Ca2+]i
response to the activation of the receptors. Furthermore, we showed
that BDNF differentially upregulates the NR1, NR2A and NR2B
NMDA receptor subunits in cultured hippocampal neurons through
Fig. 6. BDNF increases the mRNA levels of the NR1, NR2A and NR2B
NMDA receptor subunits. The variation of NR1, NR2A and NR2B mRNA
levels was assayed by SYBR Green real-time PCR of total RNA samples,
converted to cDNA in reactions normalized to contain equal amounts of
mRNA. The cells (7 DIV) were incubated in the presence or in the absence
of 100 ng/ml BDNF, during 30 min (gray columns) or 3 h (black columns).
The results are presented as mean percentage±S.E.M. compared to the
control (unstimulated), and normalized to the reference gene 18S, and are the
average±S.E.M. of 3–7 independent experiments, performed in indepen-
dent preparations. Statistical analysis was performed by one-way ANOVA,
followed by the Dunnett's test. **P<0.01, ***P<0.001.
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different Trk receptor (TrkC), increased the protein levels of NR2A
and NR2B subunits, but was without effect on NR1. The results
showing the BDNF-induced rapid delivery of NR1 and NR2
subunits to the plasmamembrane contribute to the growing evidence
that the surface expression of NMDA receptors is dynamic and
regulated (Lan et al., 2001; Roche et al., 2001), as previously
documented for AMPA receptors (Gomes et al., 2003). If BDNF has
a similar effect on the delivery of NMDA receptors to the synapse,
this may account, at least in part, for the role of the neurotrophin in
synaptic plasticity. The delivery of NMDA receptors to the synapse
plays an important role in long-term potentiation, although the NR2
subunit involved may depend on the development stage (Barria and
Malinow, 2005; Kim et al., 2005).
Stimulation of hippocampal neurons with BDNF induced a
rapid delivery of NR1- and NR2B-containing NMDA receptors toFig. 7. BDNF increases the NR1, NR2A and NR2B subunits in the plasma membra
24 h). Following treatment, cell surface proteins were labelled by biotinylation, follo
in the plasma membrane was then determined byWestern Blot. Control (0 h) express
used as loading control. The results are the average±S.E.M. of 3–8 independent e
performed by one-way ANOVA, followed by the Dunnett's test. *P<0.05, **P<the plasma membrane, but no increase in NR2A was observed for
short incubations with the neurotrophin (Fig. 7). This upregulation
in plasma membrane-associated NMDA receptor subunits corre-
lated with an increase in the [Ca2+]i responses mediated by the
receptor (Fig. 8). The simultaneous effect on the delivery of NR1
and NR2 subunits was as expected, since both subunits are required
to form a functional NMDA receptor (Meguro et al., 1992; Monyer
et al., 1994; Dingledine et al., 1999), and occurred at a time point
when the amount of NR2B was still not significantly changed. The
rapid effect of BDNF on the traffic of NR1/NR2B subunits changes
the ratio of NR2A- and NR2B-containing NMDA receptors asso-
ciated with the membrane, and is likely to result in slower excitatory
postsynaptic currents (EPSCs) (Monyer et al., 1994). Interestingly,
a recent study showed that NR2B-containing receptors carry more
calcium charge per unit current than NR2A-containing NMDA
receptors (Sobczyk et al., 2005), and we did observe an increased
[Ca2+]i response to NMDA in BDNF-treated hippocampal neurons
(Fig. 8).
BDNF was previously shown to acutely increase tyrosine
phosphorylation of NR2B (but not NR2A) subunits in cortical and
hippocampal postsynaptic densities (Lin et al., 1998), and in
cultured hippocampal neurons (Alder et al., 2005), and the effect of
the neurotrophin on the activity of NMDA receptors in cultured
hippocampal neurons is sensitive to inhibitors of NR2B (Crozier et
al., 1999; Levine and Kolb, 2000). Our findings indicate that the
upregulation of NR2B-containing receptors associated with the
membrane accounts, at least in part, for the effect of the neuro-
trophin on the receptor activity, but the molecular mechanisms
involved remain to be determined. The mechanisms mediating the
effect of neurotrophins may be similar to those involved in insulin-
induced rapid delivery of NMDA receptors to the cell surface, since
both receptors have tyrosine kinase activity. The effect of insulin
occurs via a SNAP-25 mediated form of SNARE-dependent exocy-
tosis, and does not require direct phosphorylation of the C-terminal
tails of the receptor protein, but rather of associated targeting,
anchoring, or signalling protein(s) (Skeberdis et al., 2001).
In addition to the effect resulting from the upregulation of
plasma membrane-associated receptors, phosphorylation of
NMDA receptors may also change their electrophysiological
properties, and therefore may contribute to the change in activity
induced by BDNF (Fig. 8). BDNF acutely induces phosphorylationne. Neurons were treated with or without 100 ng/ml BDNF (30 min, 3 h and
wed by precipitation with streptavidin beads. The abundance of each subunit
ion of NMDA subunits protein was set to 100%. The transferrin receptor was
xperiments, performed in independent preparations. Statistical analysis was
0.01.
Fig. 8. BDNF increases in the [Ca2+]i responses to NMDA. Cultured hippocampal neurons were loaded with the Fura-2 fluorescence probe in the presence or in
the absence of 100 ng/ml BDNF for 40 min. Following incubation, cells were perfused with Mg2+-free Na+-salt solution for 5 min and were stimulated with
100 μMNMDA and 10 μM glycine or 30 mM KCl for 30 s. After stimulation neurons were perfused with Mg2+-free Na+-salt solution for 10 min. The maximal
[Ca2+]i response to K
+ depolarization or to NMDA-receptor stimulation was monitored in single cells as the ratio between the fluorescence at 340 nm and
380 nm. For each experimental condition, the control [Ca2+]i responses were set to 100%. The results are the average±S.E.M. of 3–4 independent experiments,
performed in independent preparations. Each experimental condition was performed in duplicate, and about 80–100 cells were analysed in each field of the
microscope. Statistical analysis was performed using the Student's t test. **P<0.01.
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densities (Suen et al., 1997; Lin et al., 1998; Alder et al., 2005),
and increases NMDA single channel open probability in cultured
hippocampal neurons (Levine et al., 1998; Levine and Kolb, 2000).
Phosphorylation of NR2B may be mediated by Fyn, a member of
the Src family, since this kinase is activated by TrkB receptors
(Narisawa-Saito et al., 1999b), and increases currents mediated by
recombinant NMDA receptor (Kohr and Seeburg, 1996). The
activity of NMDA receptors in CNS neurons was also shown to
increase following intracellular application of recombinant Src
(Wang and Salter, 1994; Kalia et al., 2004; Salter and Kalia, 2004),
and Fyn-mediated interaction between BDNF signaling and
NMDA receptors may play an important role in spatial learning
and memory (Mizuno et al., 2003). The signalling activity induced
by BDNF may also affect NMDA receptors through protein kinase
C, which modulates NMDA receptor trafficking and gating in
cultured hippocampal neurons (Lan et al., 2001). In fact, activation
of Trk receptors promotes PLCγ activity (Chao, 2003), giving rise
to diacylglicerol which activates PKC.
In contrast with the short-term effects of BDNF on the surface
expression of NR1 and NR2B subunits, longer incubations with
BDNF (24 h) increased the amount of NR2A subunits associated
with the plasma membrane, but not of NR2B, further indicating that
the traffic of the two subunits to the membrane is differentially
affected by the neurotrophin. The delayed increase in NR2A in the
membrane induced by BDNF may be secondary to the upregulation
of the subunit induced by BDNF (Fig. 1) and/or due to changes in
abundance of regulatory, motor or anchoring proteins that regulate
the traffic of the receptor, since after 24 h of stimulation of the Trk
receptors with the neurotrophin the receptors are no longer active
(Almeida et al., 2005). However, it was surprising not to observe an
increase of NR1 associated with the membrane, together with
NR2A, after long incubations with BDNF. Although this may
suggest that the delivered receptors contain more NR2A than NR1
subunits, this hypothesis is against evidences suggesting that the
NMDA receptor channels are formed as dimers of dimers (an NR1
dimmer and a NR2 dimmer) (Schorge and Colquhoun, 2003). This
BDNF-induced upregulation of NR2A associated with the plasma
membrane after long incubation periods with the neurotrophin
resembles the shift from NR2B to NR2A observed in developing
neurons (Watanabe et al., 1992; Sheng et al., 1994; Barria andMalinow, 2002; Erisir and Harris, 2003; Kobayashi et al., 2006),
resulting in faster excitatory postsynaptic currents (EPSCs) and
lower sensitivity to NR2B-selective antagonists (Carmignoto and
Vicini, 1992; Flint et al., 1997). This change is also thought to
contribute to the developmental changes in NMDA-receptor
mediated plasticity at glutamatergic synapses (Philpot et al., 2001).
In addition to the translocation of NMDA receptor subunits to
the plasma membrane, we also found that BDNF upregulated NR1,
NR2A and NR2B subunits, by a mechanism involving transcription
activation. This is supported by the results showing an increase in
the mRNA levels for the three subunits in hippocampal neurons
stimulated with BDNF (Fig. 6) and the inhibition of neurotrophin-
induced upregulation of NR1, NR2A and NR2B in the presence of
transcription inhibitors (Fig. 5). Therefore, although Trk receptor
activation by neurotrophins may stimulate protein synthesis directly
(Takei et al., 2004), without transcription induction, this mechanism
is not involved in the upregulation of NMDA receptor subunits by
BDNF in hippocampal neurons. The effects of BDNF on NMDA
receptor subunits were transient in 7 DIV cultures, most likely due
to the desensitization of the Trk receptors, followed by a decrease in
the intracellular signalling activity (Sommerfeld et al., 2000;
Almeida et al., 2005). However, in 14 DIV cultures BDNF induced
a sustained increase in the NR1 and NR2A protein levels, but not of
NR2B (Fig. 1), which may be due to a change in the turn-over rate
of the subunits in the more mature cultures. Interestingly, the
expression of NR2A but not NR2B subunit is markedly reduced in
the developing cortex of BDNF knockout mice (Margottil and
Domenici, 2003). NR1 expression is regulated by different
transcription factors, including the NF-kappaB (Liu et al., 2004)
or CREB (Lau et al., 2004), and the latter is a major mediator of
neuronal neurotrophin responses (Finkbeiner et al., 1997). NR2B
expression is also regulated by CREB (Rani et al., 2005), in
addition to AP-1 (Qiang and Ticku, 2005), which may also be
activated by BDNF-induced signalling (Li et al., 2004). Neuro-
trophin-4/5 was shown to upregulate NR2A through the immediate
early transcription factor Egr-1 in cultured cerebrocortical neurons
(Choi et al., 2004).
Stimulation of hippocampal neurons with NT3 for 6 h also
upregulated NR2A and NR2B protein levels, but was without effect
on NR1. In contrast with the effect of BDNF, NT3 did not change
the NMDA receptor subunit protein levels when 2 h of incubation
216 M.V. Caldeira et al. / Mol. Cell. Neurosci. 35 (2007) 208–219with the neurotrophin was used. Although the effects of both
neurotrophins are likely mediated by Trk receptors (TrkB and TrkC,
respectively) the differential responses may be due to a distinct
cellular localization of the receptors and/or to differences in the
magnitude of the signalling responses induced.
The BDNF-induced upregulation of NMDA receptor subunits
and activity that we observed in cultured hippocampal neurons
contrast with the lack of effect of BDNF in cerebellar granule neu-
rons incubated with the neurotrophin for 2 h or 6 h (Figs. 2D–F),
indicating that BDNF has a specific effect on hippocampal neurons.
These results contrast with the previously reported downregulation
of the NR2A receptor subunits evoked by BDNF in cerebellar
granule neurons (Brandoli et al., 1998). This discrepancy may be
due to differences in the composition of the culture medium, as well
as the use of a distinct concentration of BDNF.
In addition to the long-term effects of BDNF on the abundance
and surface expression of NMDA receptors reported in this work,
the neurotrophin was also shown to increase the NMDA receptor
cluster density and size in cultured hippocampal neurons (Elmariah
et al., 2004). Long-term stimulation of cultured cerebrocortical
neurons with BDNF also upregulated AMPA receptor subunits and
currents (Narisawa-Saito et al., 2002; Nagano et al., 2003), indi-
cating that the neurotrophin has an overall stimulatory effect on
excitatory synapses. In contrast with the effects on excitatory sy-
napses, BDNF was shown to reduce rapidly the surface expression
of GABAA receptors and GABAergic currents in cultured hippo-
campal neurons (Brunig et al., 2001).
In conclusion, our work shows that BDNF differentially upre-
gulates the plasma membrane associated NMDA receptors, and the
protein levels of the receptor subunits in cultured hippocampal
neurons. NMDA receptors play an important role in synaptic
plasticity, and there is a selective activation of NMDA receptors in
specific circuits during memory formation (Tang et al., 1999;
Lynch, 2004). The activation of NMDA receptors, together with
non-NMDA receptors, induces the synthesis and release of BDNF
(Zafra et al., 1990; Hughes et al., 1993) which may further promote
NMDA receptor activity by increasing the number of receptors
associated with the membrane. The resulting increase in calcium
entry through the NMDA receptors will also regulate numerous
other downstream signalling pathways, leading to both short-term
and long-term neuronal changes (Hardingham and Bading, 2003). If
BDNF induces a rapid synaptic delivery of NR2B-containing
receptors to the synapse, similarly to the effect observed on the
overall surface expression of NMDA receptor subunits, this may be
important to allow binding of active CaMKII to synaptic NMDA
receptors, thereby contributing to synaptic potentiation (Barria and
Malinow, 2005). This model, proposed for developing synapses,
contrasts with the role played by NR2A-NMDA receptors in
promoting surface expression of GluR1-containing AMPA recep-
tors (Kim et al., 2005), a key event in LTP in more mature synapses
(Malinow and Malenka, 2002). Interestingly, BDNF also caused a
delayed increase in NR2A associated with the plasma membrane.
Experimental methods
Hippocampal cultures
Primary cultures of rat hippocampal neurons were prepared from the
hippocampi of E18–E19 Wistar rat embryos, after treatment with trypsin
(0.06%, 15 min, 37 °C; GIBCO Invitrogen, Paisley, UK) and deoxyr-
ibonuclease I (5.36 mg/ml), in Ca2+- and Mg2+-free Hank’s balanced salt
solution (HBSS; 5.36 mM KCl, 0.44 mM KH2PO4, 137 mM NaCl,4.16 mM NaHCO3, 0.34 mM Na2HPO4.2H2O, 5 mM glucose, 1 mM
sodium pyruvate, 10 mM HEPES and 0.001% phenol red). The hippocampi
were then washed with HBSS containing 10% fetal bovine serum
(BioWittaker Europe, Belgium), to stop trypsin activity, and transferred
to Neurobasal medium (GIBCO Invitrogen) supplemented with B27
supplement (1:50 dilution; GIBCO Invitrogen), 25 μM glutamate,
0.5 mM glutamine and 0.12 mg/ml gentamycin. The cells were dissociated
in this solution and were then plated in 6 well plates (91.6×103 cells/cm2),
coated with poly-D-lysine (0.1 mg/ml), or on poly-D-lysine coated glass
coverslips, at a density of 37.5×103 cells/cm2. The cultures were
maintained in a humidified incubator of 5% CO2/95% air, at 37 °C, for
7 days or 14 days. Cultures were stimulated with 100 ng/ml BDNF (kind
gift from Regeneron, Tarrytown, NY), 100 ng/ml heat inactivated (5 min,
95 °C) BDNF or with 100 ng/ml NT3 (Peprotech, London U.K.) for the
indicated periods of time. When appropriate, 2.0 μM emetine, 2. 0 μM
anisomycin, 1.5 μM α-amanitine or 1.5 μM actinomycin D (Calbiochem, La
Jolla, CA) were added 30 min before stimulation, as indicated.
Cerebellum cultures
Cerebellar granule neurons were isolated from the cerebella of 7-day-
old Sprague–Dawley rats as previously described (Schousboe et al., 1989),
with minor modifications. Briefly, following digestion (15 min, 37 °C) with
0.2% trypsin and 0.045 mg/ml deoxyribonuclease (Sigma) in Mg2+-free
Na+-salt solution (120 mM NaCl, 5 mM KCl, 1.2 KH2PO4, 13 mM
glucose,15 mM HEPES, 0.3% BSA, pH 7.4), and dissociation in 0.03%
STI (soybean trypsin inhibitor; Sigma) and 0.04 mg/ml deoxyribonuclease
prepared in Na+-salt solution (120 mM NaCl, 5 mM KCl, 1.2 KH2PO4,
1.2 mM MgSO4, 13 mM glucose,15 mM HEPES, 0.3% BSA, pH 7.4), the
dissociated cells were centrifuged at 196×g, and washed with Basal
Medium Eagle (BME, Sigma), supplemented with 25 mM KCl, 30 mM
glucose, 26 mM NaHCO3, 100 U/ml penicillin, 0.1 mg/ml streptomycin
and 10% fetal calf serum (BioWittaker Europe). Neurons were then plated
on 6 well plates (34.4×104 cells/cm2), coated with poly-D-lysine (0.1 mg/
ml), and cultured in supplemented BME. Approximately 24 h after plating,
10 μM cytosine-1-β-D-arabino-furanoside (Sigma) was added to the culture
medium to prevent glial proliferation. The cultures were maintained in a
humidified incubator of 5% CO2/95% air, at 37 °C, for 8 days. Cultures
were stimulated with 100 ng/ml BDNF (kind gift from Regeneron) for the
indicated periods of time.
Preparation of extracts
Hippocampal and cerebellar granule neurons were washed twice with
ice-cold PBS and once more with PBS buffer supplemented with 1 mM
DTT and a cocktail of protease inhibitors (0.1 mM PMSF, CLAP: 1 μg/ml
chymostatin, 1 μg/ml leupeptin, 1 μg/ml antipain, 1 μg/ml pepstatin;
Sigma-Aldrich Química, Sintra, Portugal). The cells were then lysed with
RIPA (150 mM NaCl, 50 mM Tris–HCl, pH 7.4, 5 mM EGTA, 1% Triton,
0.5% DOC and 0.1% SDS at a final pH 7.5) supplemented with the
cocktail of protease inhibitors. After centrifugation at 16,100×g for 10 min,
protein in the supernatants was quantified using the BCA method, and the
samples were denaturated with 2× concentrated denaturating buffer
(125 mM Tris, pH 6.8, 100 mM glycine, 4% SDS, 200 mM DTT, 40%
glycerol, 3 mM sodium orthovanadate, and 0.01% bromophenol blue), at
95 °C for 5 min. NMDA receptor subunits were then analysed by Western
Blot.
Total RNA isolation and reverse transcription for Real-Time PCR
Total RNA from 7 DIV cultured hippocampal neurons was extracted
with TRizol reagent (Invitrogen, Barcelona, Spain), according to the
instructions of the manufacturer. The full content of a 6 well cell cluster
plate, with 870,000 cells/well (DIV 7), was collected for each experimental
condition. For first strand cDNA synthesis, 3 μg of total RNAwere reverse-
transcribed with AMV Reverse Transcriptase (Roche, Carnaxide, Portugal),
using Random Primer p(dN)6 (3.2 μg), dNTPs (1 mM each), MgCl2
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Buffer (10 mM Tris, 50 mM KCl, pH 8.3) and in a total volume of 40 μl.
The reaction was performed at 25 °C for 10 min, followed by 60 min at
42 °C, for primer annealing to the RNA template and cDNA synthesis,
respectively. The Reverse Transcriptase was then denatured during 5 min at
99 °C, and the sample was cooled to 4 °C for 5 min and finally stored at
−80 °C until further use.
Real-Time PCR
Real-Time PCR analysis of gene expression was performed using the
LightCycler System II (Roche, Portugal). The PCR reactions were
performed using LightCycler FastStart DNA Master SYBR Green I (Roche
et al.) in 20 μl capillaries. The primers used for amplification of genes
encoding NMDA receptor subunits were, respectively, RNFRIF2079—5′
TAC ACT GCC AAC TTG GCA GCT TTC3′ and RNRIR2591—5′CAT
GAA GAC CCC TGC CAT GTT3′ for NR1, RNRZAF1961—5′TGG CTG
CCT TCA TGA TCC A3′ and RNRZAR2312—5′TGC AGC GCA ATT
CCA TAG C3′ for NR2A, and RNRZBF1040—5′GGA TCT ACC AGT
CTA ACATG3′ and RIRNRZBR1602—5′GATAGT TAG TGATCC CAC
TG3′ for NR2B. The primers used for the amplification of endogenous
control gene 18S rRNA were those included in the Applied Biosystems
TaqMan Ribosomal RNA Control Reagents Kit (Porto, Portugal). Each
primer of a pair was added to the reaction mixture (10 μl) at a final
concentration of 0.8 μM with 3 mM MgCl2, in addition to the “Hot Start”
LightCycler Fast Start DNA Master SYBR Green I mix (1×) and 1. 2 μl of
cDNA sample. Thermal cycling was initiated with activation of the FastStart
Taq DNA Polymerase by denaturation during 10 min at 95 °C, followed by
45 cycles of a 30 s melting step at 95 °C, a 5 s annealing step at 58 °C, and a
25 s elongation step at 72 °C (all temperature transition rates at 20 °C/s).
After amplification for 45 cycles, at least 10 cycles beyond the beginning of
the linear phase of amplification, samples were subjected to a melting curve
analysis according to the instructions of the manufacturer in order to confirm
the absence of unspecific amplification products and primer–dimers. In all
experiments, samples containing no template were included as negative
controls.
mRNA quantitative analysis
The mRNA levels of the constitutively expressed housekeeping gene
encoding 18S ribosomal RNAwere used as a control, in all experiments. The
relative changes in the mRNA levels of glutamate receptor subunits in
cultured hippocampal neurons were determined using the ΔΔCp method.
Accordingly, for each experimental condition (unstimulated neurons and
neurons treated with 100 ng/ml BDNF for 30 min or 3 h) the “Crossing
point” (Cp) values given by the LightCycler system II software, for each
target gene, were subtracted by the respective Cp value determined for the
18S gene for the same sample and condition (ΔCp). This allows normalizing
changes in target gene expression. Afterwards, the ΔCp values were
subtracted by the respective values of the control for the target gene giving
ΔΔCp. The derivation to the formula 2− (ΔΔCp) sets each control at the unity
(or 100%), since ΔΔCp (control)=0 and the stimuli conditions used were at a
percentage relative to the control.
Surface biotinylation and precipitation
Hippocampal cell cultures (7 DIV) were treated or not with 100 ng/ml
BDNF and then incubated with 1 mg/ml EZ-LinkTM Sulfo-NHS-SS-biotin
(Pierce, Madison, WI) in ice-cold PBS containing 1 mM CaCl2 and 1 mM
MgCl2, for 30 min (Gomes et al., 2004). The non-bound biotin was removed
by washing the cells with PBS containing 100 mM glycine. Cell lysates were
obtained as described above, and were incubated with UltraLink Plus™
immobilized streptavidin beads (Pierce), for 2 h at 4 °C, under constant
agitation. Non-biotinylated proteins were removed by centrifugation at
2500×g for 3 min, and the beads were washed three times with RIPA buffer.
Biotinylated proteins were then eluted with denaturating buffer at 95 °C for
5 min. Samples were then processed for Western Blotting analysis.Western blotting
Protein samples were separated by SDS-PAGE, in 6% polyacrylamide
gels, transferred to polyvinylidene (PVDF) membranes (BioRad, Amadora,
Portugal), and immunoblotted. Blots were incubated with primary antibodies
(overnight at 4 °C), washed and exposed to alkaline phosphatase-conjugated
secondary antibodies (1:20000 dilution; 1 h at room temperature). Alkaline
phosphatase activity was visualized by ECF on the Storm 860 Gel and Blot
Imaging System (Amersham Biosciences, Buckinghamshire, UK). The
following primary antibodies were used: anti-NR1 (1:200, Chemicon
International, Temecula, CA), anti-NR2A (1:750, Chemicon International,
Temecula, CA or 1:300, BD Transduction Laboratories, Erembodegem,
Belgium) and anti-NR2B (1:400, BD Transduction Laboratories). Anti-β-
Tubulin I (1:700,000; Sigma) and anti-transferrin receptor (1:3000; Zymed,
South San Francisco, CA) antibodies were used as loading controls.
Single cell [Ca2+]i measurements
Changes in the [Ca2+]i were assessed by monitoring the Fura-2
(Invitrogen-Molecular Probes, Leiden, The Netherlands) fluorescence ratio
(F340/F380). Seven DIV hippocampal neurons were loaded in a Mg2+-free
Na+-salt solution (132 mMNaCl, 4 mMKCl, 2.5 mMCaCl2, 6 mMGlucose,
10 mM Hepes, 10 mM NaHCO3, pH 7.4) containing 5 μg/ml Fura-2/AM,
0.2% pluronic acid F-127 (Invitrogen-Molecular Probes) and 0.1% fatty
acid-free bovine serum albumin, in the presence or absence of 100 ng/ml
BDNF, for 40 min at 37 °C. After incubation, the glass coverslips were
mounted on a RC-20 chamber in a PH3 platform (Warner Instruments,
Hamden, CT), at room temperature, on the stage of an inverted fluorescence
microscope Axiovert 200 (Zeiss). Neurons were continuously perfused with
a Mg2+-free Na+-salt solution, for 5 min, and were then stimulated with
100 μM NMDA and 10 μM glycine, or with 30 mM KCl (Na+ was
isoosmotically replaced by KCl), for 30 s. After stimulation neurons were
again perfused with a Mg2+-free Na+-salt solution, for 10 min. Solutions
were added to the cells by a fast-pressurized (95% air, 5% CO2 atmosphere)
system (AutoMate Scientific Inc, San Francisco, CA). The cells were
alternately excited at 340 and 380 nm using a Lambda DG4 apparatus
(Sutter Instruments Company, Novato, CA). Changes in the fluorescence
ratio of Fura-2 were acquired with a 40× objective and a CollSNAP HQ
digital camera (Roper Scientific, Tucson, AZ), and processed using the
MetaFluor software (Universal Imaging Corporation, Downingtown, PA).
The results are presented as the ratio of fluorescence intensities after
excitation at 340 nm and at 380 nm.
Statistical analysis
Statistical analysis was performed using one-way ANOVA analysis of
variance followed by the Dunnett’s test, or Bonferroni test, or using the
Student’s t test, as indicated in the figure captions.
Acknowledgments
We would like to thank Dr. Gina Marrão (Faculty of Medicine,
University of Coimbra) for gently providing us the use of the
LightCycler System II, Regeneron for the kind gift of BDNF and
Fundação para a Ciência e Tecnologia and FEDER for financial
support (grants POCTI/BCI/46466/2002 and SFRH/BD/9692/
2002). We also thank Elisabete Carvalho for assistance in the pre-
parations of cell cultures.
References
Alder, J., Thakker-Varia, S., Crozier, R.A., Shaheen, A., Plummer, M.R.,
Black, I.B., 2005. Early presynaptic and late postsynaptic components
contribute independently to brain-derived neurotrophic factor-induced
synaptic plasticity. J. Neurosci. 25, 3080–3085.
218 M.V. Caldeira et al. / Mol. Cell. Neurosci. 35 (2007) 208–219Almeida, R.D., Manadas, B.J., Melo, C.V., Gomes, J.R., Mendes, C.S.,
Graos, M.M., Carvalho, R.F., Carvalho, A.P., Duarte, C.B., 2005.
Neuroprotection by BDNF against glutamate-induced apoptotic cell
death is mediated by ERK and PI3-kinase pathways. Cell Death Differ.
12, 1329–1343.
Barria, A., Malinow, R., 2002. Subunit-specific NMDA receptor trafficking
to synapses. Neuron 35, 345–353.
Barria, A., Malinow, R., 2005. NMDA receptor subunit composition
controls synaptic plasticity by regulating binding to CaMKII. Neuron 48,
289–301.
Bramham, C.R., Messaoudi, E., 2005. BDNF function in adult synaptic
plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol. 76,
99–125.
Brandoli, C., Sanna, A., De Bernardi, M.A., Follesa, P., Brooker, G.,
Mocchetti, I., 1998. Brain-derived neurotrophic factor and basic fibro-
blast growth factor downregulate NMDA receptor function in cerebellar
granule cells. J. Neurosci. 18, 7953–7961.
Brunig, I., Penschuck, S., Berninger, B., Benson, J., Fritschy, J.M., 2001.
BDNF reduces miniature inhibitory postsynaptic currents by rapid
downregulation of GABAA receptor surface expression. Eur. J. Neurosci.
13, 1320–1328.
Carmignoto, G., Vicini, S., 1992. Activity-dependent decrease in NMDA
receptor responses during development of the visual cortex. Science 258,
1007–1011.
Chao, M.V., 2003. Neurotrophins and their receptors: a convergence point
for many signalling pathways. Nat. Rev., Neurosci. 4, 299–309.
Chatterton, J.E., Awobuluyi, M., Premkumar, L.S., Takahashi, H.,
Talantova, M., Shin, Y., Cui, J., Tu, S., Sevarino, K.A., Nakanishi, N.,
Tong, G., Lipton, S.A., Zhang, D., 2002. Excitatory glycine receptors
containing the NR3 family of NMDA receptor subunits. Nature 415,
793–798.
Choi, S.Y., Hwang, J.J., Koh, J.Y., 2004. NR2A induction and NMDA
receptor-dependent neuronal death by neurotrophin-4/5 in cortical cell
culture. J. Neurochem. 88, 708–716.
Crozier, R.A., Black, I.B., Plummer, M.R., 1999. Blockade of NR2B-
containing NMDA receptors prevents BDNF enhancement of gluta-
matergic transmission in hippocampal neurons. Learn. Mem. 6,
257–266.
Dechant, G., 2001. Molecular interactions between neurotrophin receptors.
Cell Tissue Res. 305, 229–238.
Dingledine, R., Borges, K., Bowie, D., Traynelis, S.F., 1999. The glutamate
receptor ion channels. Pharmacol. Rev. 51, 7–61.
Duarte, C.B., Santos, P.F., Carvalho, A.P., 1996. [Ca2+]i regulation by
glutamate receptor agonists in cultured chick retina cells. Vision Res. 36,
1091–1102.
Elmariah, S.B., Crumling, M.A., Parsons, T.D., Balice-Gordon, R.J., 2004.
Postsynaptic TrkB-mediated signaling modulates excitatory and inhibi-
tory neurotransmitter receptor clustering at hippocampal synapses.
J. Neurosci. 24, 2380–2393.
Erisir, A., Harris, J.L., 2003. Decline of the critical period of visual plasticity
is concurrent with the reduction of NR2B subunit of the synaptic NMDA
receptor in layer 4. J. Neurosci. 23, 5208–5218.
Finkbeiner, S., Tavazoie, S.F., Maloratsky, A., Jacobs, K.M., Harris, K.M.,
Greenberg, M.E., 1997. CREB: A major mediator of neuronal
neurotrophin responses. Neuron 19, 1031–1047.
Fletcher, T.L., Cameron, P., De Camilli, P., Banker, G., 1991. The
distribution of synapsin I and synaptophysin in hippocampal neurons
developing in culture. J. Neurosci. 11, 1617–1626.
Flint, A.C., Maisch, U.S., Weishaupt, J.H., Kriegstein, A.R., Monyer, H.,
1997. NR2A subunit expression shortens NMDA receptor synaptic
currents in developing neocortex. J. Neurosci. 17, 2469–2476.
Gomes, A.R., Correia, S.S., Carvalho, A.L., Duarte, C.B., 2003. Regulation
of AMPA receptor activity, synaptic targeting and recycling: role in
synaptic plasticity. Neurochem. Res. 28, 1459–1473.
Gomes, A.R., Cunha, P., Nuriya, M., Faro, C.J., Huganir, R.L., Pires, E.V.,
Carvalho, A.L., Duarte, C.B., 2004. Metabotropic glutamate and
dopamine receptors co-regulate AMPA receptor activity through PKAin cultured chick retinal neurones: effect on GluR4 phosphorylation and
surface expression. J. Neurochem. 90, 673–682.
Hall, R.A., Soderling, T.R., 1997. Differential surface expression and
phosphorylation of the N-methyl-D-aspartate receptor subunits NR1 and
NR2 in cultured hippocampal neurons. J. Biol. Chem. 272, 4135–4140.
Hardingham, G.E., Bading, H., 2003. The Yin and Yang of NMDA receptor
signalling. Trends Neurosci. 26, 81–89.
Hughes, P., Beilharz, E., Gluckman, P., Dragunow, M., 1993. Brain-derived
neurotrophic factor is induced as an immediate early gene following
N-methyl-D-aspartate receptor activation. Neuroscience 57, 319–328.
Huh, K.H., Wenthold, R.J., 1999. Turnover analysis of glutamate receptors
identifies a rapidly degraded pool of the N-methyl-D-aspartate receptor
subunit, NR1, in cultured cerebellar granule cells. J. Biol. Chem. 274,
151–157.
Janssens, N., Lesage, A.S., 2001. Glutamate receptor subunit expression
in primary neuronal and secondary glial cultures. J. Neurochem. 77,
1457–1474.
Kalb, R., 2005. The protean actions of neurotrophins and their receptors on
the life and death of neurons. Trends Neurosci. 28, 5–11.
Kalia, L.V., Gingrich, J.R., Salter, M.W., 2004. Src in synaptic transmission
and plasticity. Oncogene 23, 8007–8016.
Kim, M.J., Dunah, A.W., Wang, Y.T., Sheng, M., 2005. Differential roles of
NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling
and AMPA receptor trafficking. Neuron 46, 745–760.
Kobayashi, K., Tsuji, R., Yoshioka, T., Mino, T., Seki, T., 2006. Perinatal
exposure to PTU delays switching from NR2B to NR2A subunits of the
NMDA receptor in the rat cerebellum. Neurotoxicology 27, 284–290.
Kohr, G., Seeburg, P.H., 1996. Subtype-specific regulation of recombinant
NMDA receptor-channels by protein tyrosine kinases of the src family.
J. Physiol. 492 (Pt. 2), 445–452.
Lan, J.Y., Skeberdis, V.A., Jover, T., Grooms, S.Y., Lin, Y., Araneda, R.C.,
Zheng, X., Bennett, M.V., Zukin, R.S., 2001. Protein kinase C modulates
NMDA receptor trafficking and gating. Nat. Neurosci. 4, 382–390.
Lau, G.C., Saha, S., Faris, R., Russek, S.J., 2004. Up-regulation of
NMDAR1 subunit gene expression in cortical neurons via a PKA-
dependent pathway. J. Neurochem. 88, 564–575.
Lessmann, V., Heumann, R., 1998. Modulation of unitary glutamatergic
synapses by neurotrophin-4/5 or brain-derived neurotrophic factor in
hippocampal microcultures: presynaptic enhancement depends on pre-
established paired-pulse facilitation. Neuroscience 86, 399–413.
Levine, E.S., Kolb, J.E., 2000. Brain-derived neurotrophic factor increases
activity of NR2B-containing N-methyl-D-aspartate receptors in excised
patches from hippocampal neurons. J. Neurosci. Res. 62, 357–362.
Levine, E.S., Crozier, R.A., Black, I.B., Plummer, M.R., 1998. Brain-
derived neurotrophic factor modulates hippocampal synaptic transmis-
sion by increasing N-methyl-D-aspartic acid receptor activity. Proc. Natl.
Acad. Sci. U. S. A. 95, 10235–10239.
Li, Z., Ding, M., Thiele, C.J., Luo, J., 2004. Ethanol inhibits brain-derived
neurotrophic factor-mediated intracellular signaling and activator
protein-1 activation in cerebellar granule neurons. Neuroscience 126,
149–162.
Lin, S.Y., Wu, K., Levine, E.S., Mount, H.T., Suen, P.C., Black, I.B., 1998.
BDNF acutely increases tyrosine phosphorylation of the NMDA
receptor subunit 2B in cortical and hippocampal postsynaptic densities.
Brain Res. Mol. Brain Res. 55, 20–27.
Liu, A., Hoffman, P.W., Lu, W., Bai, G., 2004. NF-kappaB site interacts with
Sp factors and up-regulates the NR1 promoter during neuronal
differentiation. J. Biol. Chem. 279, 17449–17458.
Lu, B., Pang, P.T., Woo, N.H., 2005. The yin and yang of neurotrophin
action. Nat. Rev. Neurosci. 6, 603–614.
Lynch, M.A., 2004. Long-term potentiation and memory. Physiol. Rev. 84,
87–136.
Malinow, R., Malenka, R.C., 2002. AMPA receptor trafficking and synaptic
plasticity. Annu. Rev. Neurosci. 25, 103–126.
Margottil, E., Domenici, L., 2003. NR2A but not NR2B N-methyl-D-
aspartate receptor subunit is altered in the visual cortex of BDNF-knock-
out mice. Cell. Mol. Neurobiol. 23, 165–174.
219M.V. Caldeira et al. / Mol. Cell. Neurosci. 35 (2007) 208–219Meguro, H., Mori, H., Araki, K., Kushiya, E., Kutsuwada, T., Yamazaki, M.,
Kumanishi, T., Arakawa, M., Sakimura, K., Mishina, M., 1992.
Functional characterization of a heteromeric NMDA receptor channel
expressed from cloned cDNAs. Nature 357, 70–74.
Messaoudi, E., Ying, S.W., Kanhema, T., Croll, S.D., Bramham, C.R., 2002.
Brain-derived neurotrophic factor triggers transcription-dependent, late
phase long-term potentiation in vivo. J. Neurosci. 22, 7453–7461.
Mizuno, M., Yamada, K., He, J., Nakajima, A., Nabeshima, T., 2003.
Involvement of BDNF receptor TrkB in spatial memory formation.
Learn. Mem. 10, 108–115.
Monyer, H., Burnashev, N., Laurie, D.J., Sakmann, B., Seeburg, P.H., 1994.
Developmental and regional expression in the rat brain and functional
properties of four NMDA receptors. Neuron 12, 529–540.
Muzet, M., Dupont, J.L., 1996. Enhancement of NMDA receptor maturation
by BDNF in cultured mouse cerebellar granule cells. NeuroReport 7,
548–552.
Nagano, T., Yanagawa, Y., Obata, K., Narisawa-Saito, M., Namba, H., Otsu,
Y., Takei, N., Nawa, H., 2003. Brain-derived neurotrophic factor upre-
gulates and maintains AMPA receptor currents in neocortical GABA-
ergic neurons. Mol. Cell. Neurosci. 24, 340–356.
Nakazawa, T., Komai, S., Tezuka, T., Hisatsune, C., Umemori, H., Semba,
K., Mishina, M., Manabe, T., Yamamoto, T., 2001. Characterization of
Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B)
subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 276,
693–699.
Narisawa-Saito, M., Carnahan, J., Araki, K., Yamaguchi, T., Nawa, H.,
1999a. Brain-derived neurotrophic factor regulates the expression of
AMPA receptor proteins in neocortical neurons. Neuroscience 88,
1009–1014.
Narisawa-Saito, M., Silva, A.J., Yamaguchi, T., Hayashi, T., Yamamoto, T.,
Nawa, H., 1999b. Growth factor-mediated Fyn signaling regulates alpha-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor
expression in rodent neocortical neurons. Proc. Natl. Acad. Sci. U. S. A.
96, 2461–2466.
Narisawa-Saito, M., Iwakura, Y., Kawamura, M., Araki, K., Kozaki, S.,
Takei, N., Nawa, H., 2002. Brain-derived neurotrophic factor regulates
surface expression of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepro-
prionic acid receptors by enhancing the N-ethylmaleimide-sensitive
factor/GluR2 interaction in developing neocortical neurons. J. Biol.
Chem. 277, 40901–40910.
Nong, Y., Huang, Y.Q., Salter, M.W., 2004. NMDA receptors are movin’ in.
Curr. Opin. Neurobiol. 14, 353–361.
Philpot, B.D., Sekhar, A.K., Shouval, H.Z., Bear, M.F., 2001. Visual
experience and deprivation bidirectionally modify the composition and
function of NMDA receptors in visual cortex. Neuron 29, 157–169.
Prybylowski, K., Fu, Z., Losi, G., Hawkins, L.M., Luo, J., Chang, K.,
Wenthold, R.J., Vicini, S., 2002. Relationship between availability of
NMDA receptor subunits and their expression at the synapse. J. Neurosci.
22, 8902–8910.
Qiang, M., Ticku, M.K., 2005. Role of AP-1 in ethanol-induced N-methyl-
D-aspartate receptor 2B subunit gene up-regulation in mouse cortical
neurons. J. Neurochem. 95, 1332–1341.
Rani, C.S., Qiang, M., Ticku, M.K., 2005. Potential role of cAMP response
element-binding protein in ethanol-induced N-methyl-D-aspartate recep-
tor 2B subunit gene transcription in fetal mouse cortical cells. Mol.
Pharmacol. 67, 2126–2136.
Roche, K.W., Standley, S., McCallum, J., Dune Ly, C., Ehlers, M.D.,
Wenthold, R.J., 2001. Molecular determinants of NMDA receptor inter-
nalization. Nat. Neurosci. 4, 794–802.
Salter, M.W., Kalia, L.V., 2004. Src kinases: a hub for NMDA receptor
regulation. Nat. Rev., Neurosci. 5, 317–328.
Schorge, S., Colquhoun, D., 2003. Studies of NMDA receptor function and
stoichiometry with truncated and tandem subunits. J. Neurosci. 23,
1151–1158.Schratt, G.M., Nigh, E.A., Chen, W.G., Hu, L., Greenberg, M.E., 2004.
BDNF regulates the translation of a select group of mRNAs by a
mammalian target of rapamycin-phosphatidylinositol 3-kinase-depen-
dent pathway during neuronal development. J. Neurosci. 24,
7366–7377.
Schousboe, A., Meier, E., Drejer, J., Herz, L., 1989. Preparation of
primary cultures of mouse (rat) cerebellar granule cells. In: Shahar, A.,
De Vellis, J., Vernadakis, A., Haber, B. (Eds.), A Dissection and
Tissue Culture Manual of the Nervous System. Alan R. Liss, New
York, pp. 203–206.
Sheng, M., Cummings, J., Roldan, L.A., Jan, Y.N., Jan, L.Y., 1994.
Changing subunit composition of heteromeric NMDA receptors during
development of rat cortex. Nature 368, 144–147.
Skeberdis, V.A., Lan, J., Zheng, X., Zukin, R.S., Bennett, M.V., 2001.
Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the
cell surface by exocytosis. Proc. Natl. Acad. Sci. U. S. A. 98,
3561–3566.
Sobczyk, A., Scheuss, V., Svoboda, K., 2005. NMDA receptor subunit-
dependent [Ca2+] signaling in individual hippocampal dendritic spines.
J. Neurosci. 25, 6037–6046.
Sommerfeld, M.T., Schweigreiter, R., Barde, Y.A., Hoppe, E., 2000. Down-
regulation of the neurotrophin receptor TrkB following ligand binding.
Evidence for an involvement of the proteasome and differential
regulation of TrkA and TrkB. J. Biol. Chem. 275, 8982–8990.
Song, D.K., Choe, B., Bae, J.H., Park, W.K., Han, I.S., Ho, W.K., Earm,
Y.E., 1998. Brain-derived neurotrophic factor rapidly potentiates
synaptic transmission through NMDA, but suppresses it through
non-NMDA receptors in rat hippocampal neuron. Brain Res. 799,
176–179.
Stocca, G., Vicini, S., 1998. Increased contribution of NR2A subunit to
synaptic NMDA receptors in developing rat cortical neurons. J. Physiol.
507 (Pt. 1), 13–24.
Suen, P.C.,Wu, K., Levine, E.S.,Mount, H.T., Xu, J.L., Lin, S.Y., Black, I.B.,
1997. Brain-derived neurotrophic factor rapidly enhances phosphoryla-
tion of the postsynaptic N-methyl-D-aspartate receptor subunit 1. Proc.
Natl. Acad. Sci. U. S. A. 94, 8191–8195.
Takei, N., Numakawa, T., Kozaki, S., Sakai, N., Endo, Y., Takahashi, M.,
Hatanaka, H., 1998. Brain-derived neurotrophic factor induces rapid and
transient release of glutamate through the non-exocytotic pathway from
cortical neurons. J. Biol. Chem. 273, 27620–27624.
Takei, N., Kawamura, M., Hara, K., Yonezawa, K., Nawa, H., 2001.
Brain-derived neurotrophic factor enhances neuronal translation by
activating multiple initiation processes: comparison with the effects of
insulin. J. Biol. Chem. 276, 42818–42825.
Takei, N., Inamura, N., Kawamura, M., Namba, H., Hara, K., Yonezawa,
K., Nawa, H., 2004. Brain-derived neurotrophic factor induces
mammalian target of rapamycin-dependent local activation of transla-
tion machinery and protein synthesis in neuronal dendrites. J. Neurosci.
24, 9760–9769.
Tang, Y.P., Shimizu, E., Dube, G.R., Rampon, C., Kerchner, G.A., Zhuo, M.,
Liu, G., Tsien, J.Z., 1999. Genetic enhancement of learning and memory
in mice. Nature 401, 63–69.
Tovar, K.R., Westbrook, G.L., 1999. The incorporation of NMDA receptors
with a distinct subunit composition at nascent hippocampal synapses in
vitro. J. Neurosci. 19, 4180–4188.
Wang, Y.T., Salter, M.W., 1994. Regulation of NMDA receptors by tyrosine
kinases and phosphatases. Nature 369, 233–235.
Watanabe, M., Inoue, Y., Sakimura, K., Mishina, M., 1992. Developmental
changes in distribution of NMDA receptor channel subunit mRNAs.
NeuroReport 3, 1138–1140.
Zafra, F., Hengerer, B., Leibrock, J., Thoenen, H., Lindholm, D., 1990.
Activity dependent regulation of BDNF and NGF mRNAs in the rat
hippocampus is mediated by non-NMDA glutamate receptors. EMBO J.
9, 3545–3550.
